President Joe Biden reportedly wants to campaign for Vice President Kamala Harris in the final days leading up to the election, but Harris’ campaign appears hesitant to accept, according to a report by Axios.
The Harris team is said to be reluctant to outright reject Biden’s offer, instead choosing to avoid direct communication about setting up campaign events. A source familiar with the situation compared it to a slow-moving break-up.
“Harris’ team and allies respect Biden’s service, but are wary of further tying Harris to the unpopular president on the campaign trail,” Axios reported.
This reluctance comes as Biden’s approval rating hovers at 39 percent, according to FiveThirtyEight’s average, with widespread disapproval since his departure as the Democratic nominee.
“He’s a reminder of the last four years, not the new way forward,” another source told Axios, noting that Harris is aiming to position her campaign as a fresh direction for the country, despite serving as vice president under the current administration. […]
— Read More: thepostmillennial.com
What Would You Do If Pharmacies Couldn’t Provide You With Crucial Medications or Antibiotics?
The medication supply chain from China and India is more fragile than ever since Covid. The US is not equipped to handle our pharmaceutical needs. We’ve already seen shortages with antibiotics and other medications in recent months and pharmaceutical challenges are becoming more frequent today.
Our partners at Jase Medical offer a simple solution for Americans to be prepared in case things go south. Their “Jase Case” gives Americans emergency antibiotics they can store away while their “Jase Daily” offers a wide array of prescription drugs to treat the ailments most common to Americans.
They do this through a process that embraces medical freedom. Their secure online form allows board-certified physicians to prescribe the needed drugs. They are then delivered directly to the customer from their pharmacy network. The physicians are available to answer treatment related questions.
